Abstract-In a recent study, we found marked increases in nitric oxide (NO) production and endothelial and inducible NO synthase (eNOS and iNOS) expressions with calcium channel blockade in rats with chronic renal failure. This study was undertaken to determine whether enhanced NO production with calcium channel blockade is a direct effect of this therapy or a consequence of the associated hemodynamic and humoral changes. We tested the effects of a calcium channel blocker, felodipine (10 Ϫ5 , 10 Ϫ6 , and 10 Ϫ7 mol/L), on nitrate and nitrite (NOx) generation, Ca 2ϩ -dependent and -independent NOS activity, and eNOS and iNOS protein masses in proliferating and quiescent rat aortic endothelial cells in culture. Compared with vehicle alone, felodipine significantly increased NOx generation, Ca 2ϩ -dependent NOS activity, and eNOS protein mass in proliferating and quiescent endothelial cells. Felodipine did not modify the stimulatory action of 10% fetal calf serum on DNA synthesis (thymidine incorporation) and cell proliferation. Ca 2ϩ -independent NOS activity and iNOS protein expression were negligible and unaffected by calcium channel blockade. NOx production and NOS expression were greater in proliferating cells than in quiescent cells. Thus, calcium channel blockade upregulates endothelial NO production in vitro, confirming our previous in vivo study. This observation indicates that the reductions in cytosolic [Ca 2ϩ ] and vasodilation with calcium channel blockade are not only due to inhibition of Ca 2ϩ entry but also to an NO-cGMP-mediated mechanism. (Hypertension. 1998;32:718-723.)Key Words: calcium channel blockers Ⅲ endothelium-derived relaxing factor Ⅲ nitric oxide Ⅲ nitric oxide synthase Ⅲ rats, inbred SHR N itric oxide (NO), otherwise known as endotheliumderived relaxing factor (EDRF), plays an important role in blood pressure homeostasis. In addition, NO inhibits platelet adhesion and cell proliferation.1 Thus, normal production of NO can protect renal and systemic vasculature against pressure-dependent and pressure-independent mechanisms that lead to glomerular and arteriolar sclerosis. In fact, inhibition of NO production by NO synthase (NOS) inhibitor causes sustained hypertension, vascular injury, and glomerulosclerosis.2 Interestingly, calcium channel blockade has been shown to mitigate hypertension, improve NO production, and prevent vascular and glomerular injury in rats subjected to chronic NOS blockade.2 In addition, administration of the calcium channel blocker nicardipine has been shown to reverse the age-dependent decline in brain NOS activity and NO production in the senescent mouse.3 Likewise, chronic administration of the calcium channel blocker RO-5967 mitigated hypertension, reduced intimal inflammatory infiltrate, and improved acetylcholine-induced vasorelaxation of aortic rings in spontaneously hypertensive rats. 4 In a recent study we demonstrated a marked reduction of NO production together with depressed vascular and remnant kidney NOS activity, as well as endothelial and inducibl...